Cardiff Oncology Stock (NASDAQ: CRDF) stock price, news, charts, stock research, profile.
Open | $2.36 |
Close | $2.43 |
Volume / Avg. | 326.85K / 675.89K |
Day Range | 2.32 - 2.47 |
52 Wk Range | 0.94 - 6.42 |
Market Cap | $104.24M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 9.71% |
Days to Cover | 3.52 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cardiff Oncology (NASDAQ:CRDF) through any online brokerage.
Other companies in Cardiff Oncology’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), Armata Pharmaceuticals (AMEX:ARMP) and Vistagen Therapeutics (NASDAQ:VTGN).
There is no analysis for Cardiff Oncology.
Cardiff Oncology has a consensus price target of $9.00.
The stock price for Cardiff Oncology (NASDAQ: CRDF) is $2.33 last updated July 23, 2024 at 4:54 PM EDT.
There are no upcoming dividends for Cardiff Oncology.
Cardiff Oncology’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Cardiff Oncology.
Cardiff Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.